RUFAI UMAR ZUBAIR

Mr. RUFAI UMAR ZUBAIR


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
KSKendra Smith
Kendra Smith
RZRUFAI UMAR ZUBAIR
RUFAI UMAR ZUBAIR
RSRichard Vance Smith
Richard Vance Smith
SAStelby Augustine
Stelby Augustine
NSNicolas F. Schlecht
Nicolas F. Schlecht
TBThomas James Belbin
Thomas James Belbin
Background: Novel ZNF genes, such as ZNF671, that are located on chromosome 19q13 are known to be hypermethylated at a high frequency in HNSCC as well as in other epithelial solid tumors. Their function is largely unknown. Results: Here, we show that ZNF671 is epigenetically silenced in HNSCC primary tumors compared to matched adjacent normal tissue. Moreover, low expression of ZNF671 is significantly associated with decreased survival in HNSCC patients. Over-expression of ZNF671 in UM-SCC-1 oral cancer cells resulted in a significant reduction in tumor cell mobility and invasion compared to the empty-vector control cells. Transcriptomic analysis showed that ZNF671 re-expression resulted in a significant decrease in the expression of a major oncogenic long non-coding RNA LINC00665. Conclusions: Together, these results suggest that epigenetic silencing of ZNF671 may activate multiple oncogenic signaling pathways via the resulting up-regulation of LINC00665.

22 August 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
RZRUFAI UMAR ZUBAIR
RUFAI UMAR ZUBAIR
KSKendra Smith
Kendra Smith
RSRichard Vance Smith
Richard Vance Smith
SAStelby Augustine
Stelby Augustine
NSNicolas F. Schlecht
Nicolas F. Schlecht
TBThomas James Belbin
Thomas James Belbin
Novel ZNF proteins such as ZNF671 that are located on chromosome 19q13 are known to be hypermethylated at a high frequency in HNSCC as well as in other epithelial solid tumors. Their function is largely unknown. Here, we show that ZNF671 is epigenetically silenced in HNSCC primary tumors compared to matched adjacent normal tissue. Moreover, low expression of ZNF671 is significantly associated with decreased survival in HNSCC patients. Over-expression of ZNF671 in UM-SCC-1 oral cancer cells resulted in a significant reduction in tumor cell mobility and invasion compared to the empty-vector control cells. Transcriptomic analysis showed that ZNF671 re-expression resulted in a significant decrease in the expression of a major oncogenic long non-coding RNA LINC00665. Together, these results suggest that epigenetic silencing of ZNF671 may activate multiple oncogenic signaling pathways via the resulting up-regulation of LINC00665.